Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pCHIMES: Home-based Xofluza for Influenza
NCT04141930Phase 4Completed
- Sponsor
- University of Washington
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baloxavir marboxil in influenza, sponsored by University of Washington. Primary endpoint: Initiate Antiviral Therapy Within 48 Hours of Symptom Onset. Started Nov 2019; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04141930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141930.